A user trying to avoid an expensive hair transplant, and the replies suggesting they wait two years on treatment before deciding if they need a transplant or not.
The conversation discusses microneedling techniques and the use of Minoxidil, copper peptides, EGF, FGF, ceramides, and hydration serums to enhance hair growth. It explores optimizing scalp conditions and the potential benefits of various compounds in conjunction with microneedling.
A user shared their positive experience with finasteride, noting significant hair regrowth over two years without using other treatments. They reported initial brain fog but no other side effects, and others in the conversation expressed encouragement and shared their own experiences with finasteride.
The user started using topical minoxidil and recently added oral finasteride to their routine, seeing some progress but seeking advice on further hairline improvement. Other users shared their positive experiences with minoxidil and finasteride, suggesting patience and a simplified routine for better results.
A 20-year-old reports significant hair regrowth and darkening after 3 months of using oral finasteride and minoxidil, with no side effects. The user also notes increased beard and body hair growth, and the treatment costs about 12€ monthly.
EDHARRINGTON's journey to regrow his hair using finasteride, topical minoxidil, and micro-needling treatments over 4 years, with others commenting their support and admiration for his results.
The conversation is about the potential cost of GT20029 if FDA approved, with estimates around $150/month. Comparisons are made between GT20029, finasteride, and their mechanisms and side effects.
The conversation discusses androgen receptor degraders for hair loss, highlighting their potential advantages over traditional AR blockers like RU58841 and pyrilutamide. Concerns about the safety and cost of these treatments are also mentioned.
The conversation humorously discusses hair loss and subtle differences in hairlines, with references to Norwood scale stages. It satirizes the idea of asking AI for hair advice.
A 41-year-old shared 15 months of hair loss progress using Dutasteride, oral Minoxidil, RU58841, and weekly derma rolling or stamping, reporting no side effects. The treatments are working slowly but effectively.
The user experienced significant hair improvement over nine months using a routine of oral finasteride, mixed topical and oral minoxidil, microneedling, and Head & Shoulders shampoo. The user attributes the progress to oral minoxidil and reduced stress during paternity leave.
The post discusses the potential of GT20029 in treating hair loss, questioning if it will replace finasteride or be used alongside existing treatments. A reply indicates that its role is still uncertain.
A user's update on their hair loss treatments, which included Minoxidil and finasteride; they are experiencing reduced shedding with minimal side effects. Other users provided additional advice to the poster based on their own experiences.
Kintor plans to release pyrilutamide foam and a plant-based Koshine by year-end, with GT20029 progressing in their pipeline. Users are pleased about the absence of propylene glycol (PG) in the new products.
New potential hair loss treatment uses molecules from hairy moles to stimulate follicle growth. Topical solution requires less frequent application, like Botox injections a few times per year.
The conversation is about a 29-year-old male using finasteride until November 2024, then switching to dutasteride 0.5mg daily and adding minoxidil in February 2025, with noticeable hair regrowth and no side effects. Users comment positively on the progress, including improved hair in the front and increased armpit hair.
The conversation discusses hair regrowth progress from November 2023 to April 2024 using 1mg finasteride, 5% minoxidil, and weekly dermarolling. The consensus is that there is some improvement and increased density, with expectations of further progress.
The user has been using finasteride, minoxidil, and dermastamping, and started HRT 4 months ago but feels discouraged about progress. Other users see significant improvement and offer encouragement.
People are discussing the potential of a new hair loss treatment, pp405, and its approval timeline, comparing it to existing treatments like Minoxidil and finasteride. There is skepticism about its effectiveness and concerns about the time it will take for approval and availability, especially in Europe.
After 7 months of using topical finasteride/minoxidil, microneedling, and Nizoral shampoo, the user believes they are seeing hair regrowth. They are seeking further advice to improve their results, excluding hair transplant options.
The user is using oral minoxidil and topical finasteride for hair loss and has noticed minor improvements after 27 days, including baby hairs along the hairline. They are also using a combination spray of topical finasteride and minoxidil.
KX-826 Pyrilutamide 1% is launching soon, and users are discussing its potential benefits and drawbacks compared to other treatments like Minoxidil and finasteride. Some users are skeptical about its effectiveness, while others are hopeful it will be a safer alternative.
A 28-year-old man is considering whether to proceed with a hair transplant in February or continue using oral minoxidil, finasteride, and dermastamping, which have shown great progress in 3.5 months, to achieve desired results by his wedding in September 2026. Most responses suggest postponing the transplant to avoid potential "shock loss" and relying on the current treatment and hair fibers for the wedding.
PP405 is expected to be on the market between 2027 and 2030, with phase 3 trials starting in 2026. There is skepticism about its fast-tracking due to its cosmetic nature, and it may appear on the gray market sooner.
The user started using 1mg finasteride and Regaine foam post-hair transplant, noticing significant hair growth at three months. They experienced testicular cramps as a side effect but no other issues, and are considering microneedling for further improvement.
Verteporfin is discussed as a potential treatment for hair regrowth, but skepticism exists about its effectiveness in regenerating extracted hair follicles. The conversation also mentions the possibility of needing a hair transplant by 2028.
Finasteride and minoxidil are praised for effectively treating hair loss, with users sharing positive experiences and some discussing side effects. Others express concerns about limited treatment options and the need for more research and alternatives.
The conversation discusses the potential for Verteporfin to reduce scarring, making hairline lowering surgeries more viable for men with mild hair loss. The user suggests that if scarring can be minimized, men might opt for hairline lowering instead of using grafts for other areas.
Clascoterone has shown promising results in increasing hair density without systemic side effects, potentially offering benefits similar to finasteride. There is skepticism due to the lack of published photos despite the market interest.